Incremental cost-effectiveness of laser therapy for visual loss secondary to branch retinal vein occlusion

References

• The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271–282.
   PubMed Web of Science ®Google Scholar
• Brown GC, Sharma S, Brown MM, Garrett S. Evidence-based medicine and cost-effectiveness. J Healthcare Fin. 1999;26:14–23.
   PubMedGoogle Scholar
• Redelmeier DA, Detsky AS. A clinician's guide to utility measurement. In: Bergus GR, Cantor SB, editors. Primary Care. Clinics in Office Practice. Philadelphia: W.B. Saunders, 1995;22:271–280.
   PubMedGoogle Scholar
• Weinstein MC, Stasson WB. Foundations of cost-effectiveness analysis for health and medical practices. N Eng J Med. 1977;296: 716–721.
   PubMed Web of Science ®Google Scholar
• Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;2: 559–575.
   Google Scholar
• Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J OphthalmoL 1999; 128:324–330.
   PubMed Web of Science ®Google Scholar
• Brown GC. Vision and quality of life. Trans Am Ophthalmol Soc. 1999;97:473–512.
   PubMedGoogle Scholar
• Brown GC, Brown MM, Sharma S, Kistler J. Utility values associated with age-related macular degeneration. Arch OphthalmoL 2000;118:47–51.
   PubMed Web of Science ®Google Scholar
• Brown MM, Brown GC, Sharma S, Garrett S. Evidence-based medicine, utilities, and quality of life. Curr Opin OphthalmoL 1999;10:221–226.
   PubMedGoogle Scholar
• Brown GC, Brown MM, Sharma S, Tasman W, Brown H. Cost-effectiveness of therapy for threshold retinopathy of prematurity. Pediatrics. 1999;104(4):47.
   Google Scholar
• Data 3.5 for Healthcare User's Manual. Williamstown, MA: Treeage Software, Inc., 1998.
   Google Scholar
• Brown GC, Brown, MM, Sharma S, Brown H. Incremental cost-effectiveness of laser therapy for the treatment of subfoveal choroidal neovascularization. Ophthalmology. 2000;107:1374–1380.
   Google Scholar
• Brown GC, Brown MM, Sharma S, Busbee, Brown H. Incremental cost-effectiveness of laser photocoagulation for choroidal neovascularization associated with histoplasmosis. Retina. 2000;20:331–337.
   Google Scholar
• U. S. Department of Health and Human Services. Vital Statistics of the United States, 1994. Preprint of Volume II, Mortality, Part A, Section 6. Hyattsville, MD: US Department of Health and Human Services.
   Google Scholar
• Hayreh SS, Zimmerman MB, Podhaj sky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J OphthalmoL 1994;117:429–441.
   Google Scholar
• Lipscomb J, Weinstein MC, Torrance GW. Time preference. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996:214–246.
   Google Scholar
• Damodaran A. Corporate Finance. Theory and Practice. New York: John Wiley & Sons, 1997:37–65.
   Google Scholar
• PMIC. Medical Fees in the United States, woo. Nationwide charges for Medicine, Surgery. Laboratory, Radiology and Allied Health Services. Los Angeles, CA: Practice Management Information Corp., 2000.
   Google Scholar
• Kirschner CG, Davis SJ, Evans D, et al. Current Procedural Terminology woo. Chicago: American Medical Association.
   Google Scholar
• Smith A, Brown GC. Understanding cost-effectiveness: A detailed review. Br J OphthalmoL 2000;84:794–798.
   PubMedGoogle Scholar
• Laupacis A. Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization. Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J. 1992;146:473–481.
   Google Scholar
• Stone PW, Teutsch S, Chapman RH, Bell C, Goldie SJ, Neumann PJ. Cost-utility analyses for clinical preventive services. Published ratios, 1976–1997. Am J Prey Med. 2000;19: 15-2 I .
   Google Scholar
• Jacobson JJ, Schweitzer SO, Kowalski CJ. Chemoprophylaxis of prosthetic joint patients during dental treatment; a decision utility analysis. Oral Surg Oral Med Oral PathoL 199172:167–177.
   Google Scholar
• Schrader GD. Subjective and objective assessments of medical comorbidity in chronic depression. Psychother Psychosom. 1997;666: 258-26o.
   Google Scholar
• Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree. Cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. Br Med J. 1997;314:1580—I583.
   Google Scholar
• Lunde IM. Patients' perceptions. A shift in medical perspective. Scand J Prim Health Care. 1993;11:98–104.
   PubMedGoogle Scholar
• Brown GC, Brown MM, Sharma S. Difference between ophthalmologist and patients perceptions of quality-of-life associated with age-related macular degeneration. Can J Ophthalmol. 2000:35:27–32.
   Google Scholar
• Kassirer JP. Adding insult to injury: usurping patients' prerogatives. N Eng J Med. 1983;308:898–901.
   PubMed Web of Science ®Google Scholar
• Angell M. Patients' preferences in randomized clinical trials. N Eng J Med. 1984;3m:1385–1387.
   Google Scholar
• Kassirer JP. Incorporating patients' preferences into medical decisions. N Eng J Med. 1994;330:1895–1896.
   PubMed Web of Science ®Google Scholar
• Brown GC, Brown MM, Sharma S. Health care in the 21st century: Evidence-based medicine, patient preference-based quality, and cost-effectiveness. Qual Manag Health Care. 2000;9: 23–31.
   Google Scholar
• Russell LB, Gold MR, Siegel JE, Daniels D, Weinstein MC, the Panel on Cost-Effectiveness in Health and Medicine. The role of cost-effectiveness analysis in health and medicine. J Am Med Assoc. 1996;276:1172–1177.
   PubMed Web of Science ®Google Scholar
• Gold MR, Patrick DL, Torrance GW, Fryback DG, Hadorn DC, Kamlet MS, Daniels N, Weinstein MC. Identifying and valuing outcomes. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996:82–134.
   Google Scholar